Therapeutic Options for Crigler-Najjar Syndrome: A Scoping Review.

Crigler–Najjar syndrome UGT1A1 mutation gene therapy hyperbilirubinemia liver transplantation

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
13 Oct 2024
Historique:
received: 13 09 2024
revised: 01 10 2024
accepted: 11 10 2024
medline: 26 10 2024
pubmed: 26 10 2024
entrez: 26 10 2024
Statut: epublish

Résumé

Crigler-Najjar Syndrome (CNS) is a rare genetic disorder caused by mutations in the

Identifiants

pubmed: 39456788
pii: ijms252011006
doi: 10.3390/ijms252011006
pii:
doi:

Substances chimiques

Glucuronosyltransferase EC 2.4.1.17
UGT1A1 enzyme EC 2.4.1.-

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Vanessa Sambati (V)

Pediatric Clinic, Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy.

Serena Laudisio (S)

Pediatric Clinic, Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy.

Matteo Motta (M)

Pediatric Clinic, Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy.

Susanna Esposito (S)

Pediatric Clinic, Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH